Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That is super! God bless her and help her to a speedy recovery. May she be well on her way to recovery by Christmas.
NASH 1st patient enrolled Dec 2nd 2020. How long to enroll the 60 patients and how long before readout? Tic Tok Tic Tok
Inflammation in Brain= Alzheimers Indication
Inflammation in Liver = NASH Indication
The potential for CYDY is growing exponentially
The NASH indication is the Holy Grail of Biotech and CYDY has the only proven safe drug in clinical trails for NASH.
In NASH the FDA will have no BP profits to protect as there are no approved drugs for NASH and just having a drug in clinical trials leads to multibillion dollar market caps. This is the killer indication that will lead to most of the future revenues when developed and approved.
This run is from the Covid full enrollment news. Just wait until the NASH trial is fully enrolled. That is the monster indication and will dwarf all others combined. That is what the big tutes will look at when they buy all they can of this stock.
First it was Covid. And then came NASH.eom
If you are using fully diluted shares then the dilution is ZERO because if I am not mistaken the the loan was originally made with stock conversion rights as collateral. They are just it doing now rather than later. Why would CYDY do it now rather than later?
Then the question might be, and mind you, this is speculation; taken together with the other two Form D sales of $1 million and $1.17 million and having satisfied the $7.5 million loan does this not now give CYDY a greater than $2 million shareholder equity?
If a requirement for NADAQ listing requires a $2 million shareholder equity in the stock price above $4 category would not CYDY be eligible for up listing to NASDAQ currently?
I have always believed when forging ahead one should strike while the Iron is hot.
CytoDyn is forging ahead into a revenue producing company and its Irons are hot.
Good post. The logic of this post is self evident.
One reason that AVXL loses momentum during upswing might be because of the LPC periodic stock sales capping the price. This is good for someone accumulating over a long period of time so in an not complaint just observing.
One thing Missling might consider is just a large secondary during a run up to results. Vistagen did that last night and this morning a $65mil market cap with 75 million outstanding shares did an offering for $100 million in common at $0.92 the HOD closing yesterday price with some preferred shares. Vistagen run up from that $0.92 to $1.36 today on the offering. I suppose now with $100 million they will no longer use the LPC as they used to do almost exactly like Anavex LPC facility, so investors might see room to move up now that there will not be any more LPC sales. Vistagen is a prerevenue biotech in CNS/ depression. Disclosure I own Vistagen and SAGE as well as Anavex.
Disclosure long time
It can be a surprise to everyone except NAZ and CYDY. Mulholland already made the application.
Quite possibly the last trading day on the OTC. Could start trading as CYDYD during NAZ up list Monday morning. Possibly opening at $7-8 and running up all day as Tutes load up.
All aboard the CytoDyn Express.
The offering was at HOD after 4x normal volume buying. It is under heavy Tute accumulation. The pumper is right on this one. I don't know him but I have followed the company for 5 years.
1.24 million shares premarket already after 3.28 million aftermarket last night.vs. 1.5million average daily volume last 10 days. It looks like a hostile take over attempt that is why the huge offering with the preferred shares.
By the way I did not mean to imply your thought was unsophisticated as it is correct and retail and market will discount that tech transfer time lag and view as a backlog order stiuation similar to how Boeing and the market knows planes will be sold in the future due to order backlog.
And CytoDyn may be one of the few companies with morality and compassion occupying the C Suite.
That's what the retail stock market thinks but reality is it takes one year for the transfer of technologies to the new manufacturer to start producing the drug. OWS could help if so inclined.
I am just going off what Nader said CYDY said they can produce and sell. $2 billion in product in stock and can produce and sell a total of $5-10 billion in 2021. If they get HIV and ramp up production then more of course. I am a long time Boeing investor so I base price on booked orders and delivery schedule (production capacity to deliver back logged orders) CytoDyn might have a hard time ramping production so could have a backlog.
Market might overshoot on the up side and get a frothy price on approval for anything.
I have noticed many times they do this the price rises on opening or when they wash trade it up pre market the price dives. Look at the volume scant volume means nothing pre market. Just paint.
Nader said expects $5-10 billion in sales 2021. 5 times sales is $25-50 billion. Cut that in half for execution risk gives a target of $12.5 billion to $25 billion.
My target might be roughly $20 per share.
5.7 million shares traded reg session on no news normal 10 avg volume is 1.5 million shares. AFTERHOURS prospectus filed blank price and blank number of shares. 3.28 Million shares!! Traded afterhours in a lot of big blocks of 10000 to 20000 shares. I watched in real time cross the tape. There is no rule that says when a company is buying another company or taking a major stake that will shoot up the share price that they can not buy on the open market. It looks like a buyout or major partnership is happening. 3.28 million shares in afterhours trading up as much as 36% at one point to $1.20. Do the math something is happening that may skyrocket this stock i have been invested here for over 3 years and trading the market since 1985. I have never seen anything like that afterhours on no real news in any stock i bought that hand over fist. Expect trading halts and a 200 to 400% jump.
It looks like another partnership deal is the reason for the share offering with preferred convertible shares. Not priced yet but VTGN is up another 17% in after hours with huge for after hours buys of 11k 13.6k and 18k in the last few minutes @$1.10 it traded a lot of shares at $1.16.
The founders and leaders of Gilead were compassionate and out for the betterment of mankind once until Wall Street money put the likes of Donald Rumsfelt in control. Not that Gilead does not do good work just that everything takes backseat to profits to please Wall Street money interests, at times it seems even morality and ethics.
Prayers for your wife. My your love and prayers, her hope and her doctor's care and skill restore her health.
Gotta love those old school point and figure charts from back in the day when brokers did them by hand on graph paper.
Easy to see the turning point/resistance areas. Easy to see the next resistance areas @$5, $6.5 and $10 on that traditional price scalAntoWe could see another dollar or so increase by end of the week.
Another $.50 move this week seems doable on momentum alone. Come on MOMO FOMO and short cover buyers.
The rocket is still on the launch
pad. NAZ up list might cause ignition any day now.
All of the old shares need to be returned to the Share Share Agent and then converted to the new shares. In the mean time the stock trades under a temporary symbol CYDYD. Therefore they must be covered to be returned for conversion into the new shares. When this conversion is complete the stock will revert to its old ticker CYDY. Been there done that. For a recent example see HGEN/HGEND. For an example of what it does to a heavily shorted stock when there is a surprise up list to NAZ see AVXL/AVXLD in October 2015. Known as the October Surprise with Anavex Longs.
Yes it is a breakout. 228k shares bought at 15 minutes past 2pm EST. It would make sense for a Tute to take a few days to analyse the data before commiting $1.43 million for an investment in Anavex.
Mulholland should get the ok any day now for CYDY to up lift to NAZ. The short sellers might try one more attack on the long stock holders. I hope Nader keeps the up list notification in his pocket and does a surprise up list over night after the next short attack. Maybe that and some piece of good news to release the morning of the first day of trading under the temporary ticker CYDYD. No shares to borrow to roll over the shares held short and all existing short shares would need to be covered.
Brokers usually to the force covering for margin calls starting one hour before the closing bell. CYDY is not marginable but a short sale is always on margin. Should we see continued spikes in price time a sustained series of gains this will force shorts covering.
CYDY is in the power zone! Beastmode. RSI 75% and rising. This two days of big gains are going to show up on a lot of stock raders. When CYDY hits $5 it will hit Tutes radars seeing this launch it might be a MUST OWN stock for biotech portfolios especially with up list to NAZ and an EUA.
2020 the last year CYDY trades on the OTC. 2021 the first year of CYDY revenues.
Feel the heat! The next major catalyst could be up lift to NAZ. The big joy for longs will be waking up in just a few days and see the ticker changed to CYDYD the temporary ticker for the days long transition. For shorts it will mean that they will be forced to cover during those first few transition days. I believe Nader will pull a surprise up lift as he has some justified animosity towards short sellers.
That is what AVXL did on its up lift to NAZ in 2015. It caused the stock to skyrocket.
Now here this! Pfizer vaccine is have some allergic reactions in a small number of patients. Allergic reaction = cytokine storm. There needs to be a treatment for the allergic reaction/cytokine storm for the vaccine program to continue as planned. LEronlimab needs to be immediately deployed for this with some doses going along with the vaccine to be on site already in case of allergic reaction.
If it was the CRO or Samsung that took shares instead of cash that is double good news. Either way it is cash or pay down of liabilities.
Another Form D 350000 shares at yesterdays price $3.36 for another $1.176 mil. That might be the cash needed to uplist to NAZ.
BAM! That's what I am talkin' 'bout. If CYDY does this on enrollment what is it gonna do on results then EUA?
Volume precedes price.
Well don't look a gift horse in the mouth except to check the numbers tattooed there. AVXL is a better buy today @ 5.82vs a few days ago at $5. Pros will see that and start buying this today.
The 10Q is due for release. That should be the next shoe to drop.
7.7 million shares held short. Most of those might be traded back and forth today. Covering and re-shorted at the higher water mark. That is actually good that they will likely reshort as it help put a higher floor into the stock price as profits will be taken or buy stops initiated by covering on share price at a higher price later.